Evidence map›Paper›PMID 40547015›Full record

ArticleFrontiers in immunology2025

Sigridur Jonsdottir, Sara Björk Stefansdottir, Jelena Mirkovitch, Anja Ziegler, Sigurbjörg Torsteinsdottir, Eliane Marti

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sigridur JonsdottirInstitute for Experimental Pathology, Biomedical Center, University of Iceland, Keldur, Reykjavik, Iceland.
Sara Björk StefansdottirInstitute for Experimental Pathology, Biomedical Center, University of Iceland, Keldur, Reykjavik, Iceland.
Jelena MirkovitchDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health, Vetsuisse Faculty, University of Berne, Bern, Switzerland.
Anja ZieglerDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health, Vetsuisse Faculty, University of Berne, Bern, Switzerland.
Sigurbjörg TorsteinsdottirInstitute for Experimental Pathology, Biomedical Center, University of Iceland, Keldur, Reykjavik, Iceland.
Eliane MartiDivision of Neurological Sciences, Department of Clinical Research and Veterinary Public Health, Vetsuisse Faculty, University of Berne, Bern, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Insect bite hypersensitivity (IBH) is an IgE-mediated dermatitis in horses caused by bites of Methods: Eight major Results: The eight major allergens were successfully expressed in insect cells and purified. All allergens induced a significantly higher sLT release from PBL of IBH-affected horses compared to healthy controls. There was a high correlation and substantial to excellent agreement between sLT release and serum IgE levels for six Discussion: Insect-cell-expressed

Indexed as

AllergensCeratopogonidaeHorse DiseasesHypersensitivityInsect Bites and StingsInsect ProteinsLeukocytesAnimalsFemaleHorsesImmunoglobulin EMaleAllergensImmunoglobulin EInsect ProteinsCulicoides allergenshorseinsect bite hypersensitivityinsect cell expressed recombinant proteinsserum IgEsulphidoleukotriene release

Identifiers

PMID40547015
PMCPMC12178880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.